Back to Agenda
Agility Unlocked: How Mixed FSP/FSO Models Enhance Efficiency and Facilitate the Transition from FSO to FSP Outsourcing
Session Chair(s)
Representative Invited
Greenough Communications LLC, United States
Learn how mixed FSP (functional service provider)/FSO (full-service outsourcing) models deliver additional agility to help clinical trial sponsors manage complexity, enhance efficiency, and facilitate the transition from FSO to FSP outsourcing.
Learning Objective : Identify opportunities where mixed FSP (functional service provider)/FSO (full-service outsourcing) models create additional agility in clinical trial operations; Discuss how mixed FSP/FSO models facilitate the transition from FSO to FSP outsourcing; Assess flexible options to deliver drug development on time and on budget in complex, global trials.
Speaker(s)
Moderator
Andrew Studna
Applied Clinical Trials, United States
Senior Editor
Panelist
Samantha Hadfield
Thermo Fisher Scientific, United Kingdom
Vice President, Operational Delivery, PPD FSP solutions
Panelist
Nick Scott
Biogen, United States
Head, Strategic Resourcing and Performance Optimization
Have an account?